SEBORRHEIC DERMATITIS THERAPY
US over-the-counter (OTC) label
In the United States, these products are sold as over-the-counter (OTC) drugs: sunscreens, antiperspirants, anti-dandruff products, anticavity toothpastes, acne products and skin protectants. The label separates active and inactive ingredients. In the European Union, a product with a cosmetic purpose must comply with Regulation (EC) No 1223/2009. A filter or active allowed in the United States may not be authorised for that use in the EU. The classification depends on the purpose: a hand sanitiser may fall under biocides and an acne treatment under medicines. This analysis applies the cosmetic rules to the ingredients without establishing the compliance of the finished product. The formula sold in Europe under the same name may be different.
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Stated use in the United States
Purpose Seborrheic Dermatitis Treatment
Published active ingredients
Pyrithone Zinc 1% Salicylic Acid 1,5%
Published inactive ingredients
Aloe Barbadensis Leaf Extract, Allantoin, Ascorbic Acid, Benzoic Acid, a-Bisabolol, Cetyl Alcohol, Chloroxylenol, Dehydroacetic Acid, Di-C12-13 Alkyl Malate, Dipropylene Glycol, Distilled Water, Glyceryl Monostearate, Laureth-9, Mentha Piperita Extract, Octyldodecanol, Panthenol, Paraffinum Liquidum, Phenoxyethanol, Undecylenic Acid, Urea, Xanthan Gum, Zinc Oxide
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Cosmetic analysis in the European Union
8 ingredients allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 22 names recognised out of 24.
Warning: 2 names out of 24 are not recognised (Pyrithone Zinc 1%, a-Bisabolol): nothing below covers them.
- Pregnancy and breastfeeding : Worth watching SALICYLIC ACID
- Babies and children : Prohibition or serious classification SALICYLIC ACID
Pyrithone Zinc 1%, Salicylic Acid 1,5%, Aloe Barbadensis Leaf Extract, Allantoin, Ascorbic Acid, Benzoic Acid, a-Bisabolol, Cetyl Alcohol, Chloroxylenol, Dehydroacetic Acid, Di-C12-13 Alkyl Malate, Dipropylene Glycol, Distilled Water, Glyceryl Monostearate, Laureth-9, Mentha Piperita Extract, Octyldodecanol, Panthenol, Paraffinum Liquidum, Phenoxyethanol, Undecylenic Acid, Urea, Xanthan Gum, Zinc Oxide
Who it concerns
For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Pregnancy and breastfeeding
- Worth watching SALICYLIC ACIDClassified under the CLP Regulation: reproductive toxicity, category 2 (Repr. 2), a hazard to the unborn child. The European Union nevertheless allows it under the conditions of its annex, after an opinion of its Scientific Committee on Consumer Safety (SCCS).
Babies and children
- Prohibition or serious classification SALICYLIC ACIDAnnex III, entry 98, prohibits it in products intended for children under 3: “Not to be used in preparations for children under 3 years of age.” Annex V, entry 3, prohibits it in products intended for children under 3: “Not to be used in products for children under 3 years of age.”
Skin, eyes and allergies
- Worth watching CHLOROXYLENOLClassified under the CLP Regulation: eye irritation, category 2 (Eye Irrit. 2); skin irritation, category 2 (Skin Irrit. 2); skin sensitisation, category 1 (Skin Sens. 1).
- For information SALICYLIC ACIDClassified under the CLP Regulation: serious eye damage, category 1 (Eye Dam. 1). This classification describes the pure substance; in a finished product it is far more diluted.
- For information BENZOIC ACIDClassified under the CLP Regulation: skin irritation, category 2 (Skin Irrit. 2); serious eye damage, category 1 (Eye Dam. 1). This classification describes the pure substance; in a finished product it is far more diluted.
- For information PHENOXYETHANOLClassified under the CLP Regulation: serious eye damage, category 1 (Eye Dam. 1). This classification describes the pure substance; in a finished product it is far more diluted.
Environment
- Worth watching ZINC OXIDEClassified under the CLP Regulation: hazardous to the aquatic environment, short term, category 1 (Aquatic Acute 1); hazardous to the aquatic environment, long term, category 1 (Aquatic Chronic 1).
Read on the label
- For information SALICYLIC ACIDAnnex III, entry 98, requires this to be printed on the pack: “(a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.”. Annex V, entry 3, requires this to be printed on the pack: “Salicylic acid: Not to be used for children under 3 years of age** **Solely for products which might be used for children under 3 years of age. Salicylic acid salts: Not to be used for children under 3 years of age*** ***Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.”.
For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.
Selling elsewhere
Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.
| Country | Prohibited | Prohibited in some cases | Subject to conditions |
|---|---|---|---|
| United Kingdom | - | - | Salicylic Acid 1,5%, Benzoic Acid, Chloroxylenol, Dehydroacetic Acid, Laureth-9, Phenoxyethanol, Undecylenic Acid, Zinc Oxide |
| Canada | - | - | Salicylic Acid 1,5%, Urea |
| Japan | - | - | Salicylic Acid 1,5%, Benzoic Acid, Phenoxyethanol |
| South Korea | - | - | Salicylic Acid 1,5%, Benzoic Acid, Chloroxylenol, Dehydroacetic Acid, Laureth-9, Phenoxyethanol, Undecylenic Acid, Urea, Zinc Oxide |
| Australia | - | - | Zinc Oxide |
| ASEAN | - | - | Salicylic Acid 1,5%, Benzoic Acid, Chloroxylenol, Dehydroacetic Acid, Laureth-9, Phenoxyethanol, Undecylenic Acid, Zinc Oxide |
| Taiwan | - | - | Salicylic Acid 1,5%, Allantoin, Benzoic Acid, Chloroxylenol, Dehydroacetic Acid, Phenoxyethanol, Undecylenic Acid, Urea, Zinc Oxide |
| Brazil | - | - | Salicylic Acid 1,5%, Benzoic Acid, Chloroxylenol, Dehydroacetic Acid, Phenoxyethanol, Undecylenic Acid, Zinc Oxide |
No prohibition or condition found in the recorded lists for: United States (federal), Washington State, California, China.
Ingredient by ingredient
The line under each name gives its rule in the European Union (legend below). Click a name for its page.
Hover over or tap a badge for its meaning.
Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.
| On the label | Glossary name | Rule in the European Union | Classified hazard (cancer, DNA, reproduction) |
|---|---|---|---|
| Pyrithone Zinc 1% | not recognised | Name not recognised in the European glossary | unknown |
| Salicylic Acid 1,5% | SALICYLIC ACID | Allowed with restrictions (Annex III) Preservative allowed under conditions (Annex V) Annex III, entry 98: products: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant; maximum concentration: (a) 3.0% (b) 2.0% (c) 0.5% Annex V, entry 3: maximum concentration: Salicylic acid: 0.5% (acid) Salicylic acid salts: 0.5% (acid) | Toxic for reproduction: suspected effect (category 2, CLP classification) |
| Aloe Barbadensis Leaf Extract | ALOE BARBADENSIS LEAF EXTRACT | No specific rule in the Cosmetics Regulation | none |
| Allantoin | ALLANTOIN | No specific rule in the Cosmetics Regulation | none |
| Ascorbic Acid | ASCORBIC ACID | No specific rule in the Cosmetics Regulation | none |
| Benzoic Acid | BENZOIC ACID | Preservative allowed under conditions (Annex V) Annex V, entry 1: products: a) Rinse-off products, except oral care products b) Oral care products c) Leave-on products; maximum concentration: a) 2.5% (acid) b) 1.7% (acid) c) 0.5% (acid) | none |
| a-Bisabolol | not recognised | Name not recognised in the European glossary | unknown |
| Cetyl Alcohol | CETYL ALCOHOL | No specific rule in the Cosmetics Regulation | none |
| Chloroxylenol | CHLOROXYLENOL | Preservative allowed under conditions (Annex V) Annex V, entry 26: maximum concentration: 0.5% | none |
| Dehydroacetic Acid | DEHYDROACETIC ACID | Preservative allowed under conditions (Annex V) Annex V, entry 13: maximum concentration: 0.6% (as acid) | none |
| Di-C12-13 Alkyl Malate | DI-C12-13 ALKYL MALATE | No specific rule in the Cosmetics Regulation | none |
| Dipropylene Glycol | DIPROPYLENE GLYCOL | No specific rule in the Cosmetics Regulation | none |
| Distilled Water | AQUA Certainty high: water matched after removing its physical purification qualifier | No specific rule in the Cosmetics Regulation | none |
| Glyceryl Monostearate | GLYCERYL STEARATE Certainty certain: checked synonym | No specific rule in the Cosmetics Regulation | none |
| Laureth-9 | LAURETH-9 | Allowed with restrictions (Annex III) Annex III, entry 257: products: (a) Leave-on products (b) Rinse-off products; maximum concentration: (a) 3.0% (b) 4.0% | none |
| Mentha Piperita Extract | MENTHA PIPERITA EXTRACT | No specific rule in the Cosmetics Regulation | none |
| Octyldodecanol | OCTYLDODECANOL | No specific rule in the Cosmetics Regulation | none |
| Panthenol | PANTHENOL | No specific rule in the Cosmetics Regulation | none |
| Paraffinum Liquidum | PARAFFINUM LIQUIDUM | No specific rule in the Cosmetics Regulation | none |
| Phenoxyethanol | PHENOXYETHANOL | Preservative allowed under conditions (Annex V) Annex V, entry 29: maximum concentration: 1.0% | none |
| Undecylenic Acid | UNDECYLENIC ACID | Preservative allowed under conditions (Annex V) Annex V, entry 18: maximum concentration: 0.2% (as acid) | none |
| Urea | UREA | No specific rule in the Cosmetics Regulation | none |
| Xanthan Gum | XANTHAN GUM | No specific rule in the Cosmetics Regulation | none |
| Zinc Oxide | ZINC OXIDE | UV filter allowed under conditions (Annex VI) Colorant allowed under conditions (Annex IV) Separate entry for the nano form (Annex VI) Annex VI, entry 30: maximum concentration: - 25% - In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25% | none |
Product record
- Brand or trade name
- SEBORRHEIC DERMATITIS THERAPY
- Manufacturer
- PSODEX USA INC
- Label date
- 21 December 2023
Label in the official openFDA API. This is the label date; the formula may have changed. Compare with the packaging.
List in the official revision dated (register: openFDA: US OTC product labels, analysed under European cosmetic rules).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “SEBORRHEIC DERMATITIS THERAPY”, https://compoatlas.com/en/cosmetics/united-states/0325265b-5f72-92ae-e063-6294a90a3f05-seborrheic-dermatitis-therapy, updated 21 December 2023.